Pfizer chief granted USD 1 million Genesis Prize for development of COVID-19 vaccine Dr. Divya Colin21 Jan 2022 9:30 AM ISTPfizer's vaccine was the first to win U.S. approval for emergency use in December 2020, and Israel quickly became one of the first countries to...
Pfizer-BioNTech COVID vaccine causes mostly mild side effects in children aged 5 to 11 years, says USCDC Ruchika Sharma2 Jan 2022 10:00 AM ISTNew Delhi: Pfizer Inc and BioNTech SE's COVID-19 vaccine caused mostly mild side effects in children aged 5 to 11 years, according to data...
CoronaVac third dose ineffective against Omicron, says study contrary to Sinovac claim Dr Pooja27 Dec 2021 2:51 PM ISTHong Kong: China's Sinovac Covid-19 vaccine (CoronaVac) doesn't provide sufficient antibodies to fend off Omicron, a study by two Hong Kong...
Pandemic could extend to 2024, vaccine data for younger children delayed: Pfizer Ruchika Sharma20 Dec 2021 3:30 PM ISTNew Delhi: Pfizer Inc on Friday forecast that the COVID-19 pandemic would not be behind us until 2024 and said a lower-dose version of its...
Pfizer, BioNTech seek USFDA approval for COMIRNATY in adolescents aged 12-15 years Ruchika Sharma18 Dec 2021 3:35 PM ISTNew York: Pfizer Inc. and BioNTech SE have announced they have submitted a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug...
Confident of quickly adapting vaccine for Omicron: BioNTech CEO Ruchika Sharma5 Dec 2021 11:00 AM ISTFrankfurt: Germany's BioNTech should be able to adapt its coronavirus vaccine relatively quickly in response to the Omicron variant, its CEO Ugur...
Covid-19: Pfizer-BioNTech, Moderna expect data on shot protection against new variant soon Ruchika Sharma28 Nov 2021 10:30 AM ISTFrankfurt: BioNTech SE said on Friday it expects more data on a worrying new coronavirus variant detected in South Africa within two weeks to...
FIRST: Pfizer-BioNTech gets USFDA emergency use nod for COVID vaccine in kids aged 5 through 11 years old Ruchika Sharma30 Oct 2021 1:31 PM ISTNew York: Pfizer Inc. and BioNTech SE have recently announced that the U.S. Food and Drug Administration (USFDA) has authorized for emergency use...
Pfizer COVID vaccine benefits outweigh key risks in children 5 to 11, says USFDA Ruchika Sharma23 Oct 2021 4:00 PM ISTNew Delhi: Scientists at the U.S. Food and Drug Administration (FDA) said on Friday that the likely benefits of giving the Pfizer /BioNTech COVID-19...
COVID booster shot showed high efficacy in large study: Pfizer, BioNTech Ruchika Sharma22 Oct 2021 3:01 PM ISTNew York: Pfizer Inc. and BioNTech SE have recently announced topline results from a Phase 3 randomized, controlled trial evaluating the efficacy and...
Pfizer-BioNTech seek EU agency nod for COVID vaccines for kids 5-11 Ruchika Sharma17 Oct 2021 10:00 AM ISTBerlin : Pharmaceutical company Pfizer and biotechnology company BioNTech informed they have requested to have their coronavirus vaccine licensed for...
Full vaccination with Pfizer vaccine provides protection for at least six months: Lancet Hina Zahid7 Oct 2021 8:45 AM ISTTwo doses of Pfizer-BioNTech (BNT162b2) are 90% effective against COVID-19 hospitalizations for all variants, including delta, for at least six...
